BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11120831)

  • 1. HIV-1 Tat represses transcription from the mannose receptor promoter.
    Caldwell RL; Egan BS; Shepherd VL
    J Immunol; 2000 Dec; 165(12):7035-41. PubMed ID: 11120831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells.
    Caldwell RL; Gadipatti R; Lane KB; Shepherd VL
    J Leukoc Biol; 2006 Jan; 79(1):192-201. PubMed ID: 16282533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV Tat represses transcription of the beta 2-microglobulin promoter.
    Carroll IR; Wang J; Howcroft TK; Singer DS
    Mol Immunol; 1998 Dec; 35(18):1171-8. PubMed ID: 10199391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Tat inhibits IL-2 gene transcription through qualitative and quantitative alterations of the cooperative Rel/AP1 complex bound to the CD28RE/AP1 composite element of the IL-2 promoter.
    González E; Punzón C; González M; Fresno M
    J Immunol; 2001 Apr; 166(7):4560-9. PubMed ID: 11254713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of MHC class I gene promoter activity by two-exon Tat of HIV.
    Howcroft TK; Strebel K; Martin MA; Singer DS
    Science; 1993 May; 260(5112):1320-2. PubMed ID: 8493575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
    Kamine J; Subramanian T; Chinnadurai G
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator.
    Graham GJ; Maio JJ
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5817-21. PubMed ID: 1696012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
    Robinson D; Elliott JF; Chang LJ
    Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Tat interaction with cyclin T1 represses mannose receptor and the bone morphogenetic protein receptor-2 transcription.
    Caldwell RL; Lane KB; Shepherd VL
    Arch Biochem Biophys; 2006 May; 449(1-2):27-33. PubMed ID: 16615932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation.
    Koziel H; Eichbaum Q; Kruskal BA; Pinkston P; Rogers RA; Armstrong MY; Richards FF; Rose RM; Ezekowitz RA
    J Clin Invest; 1998 Oct; 102(7):1332-44. PubMed ID: 9769325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The octamer-binding proteins Oct-1 and Oct-2 repress the HIV long terminal repeat promoter and its transactivation by Tat.
    Liu YZ; Latchman DS
    Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):155-8. PubMed ID: 9078256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tat transactivation of the human immunodeficiency virus type 1 promoter is influenced by basal promoter activity and the simian virus 40 origin of DNA replication.
    Kessler M; Mathews MB
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10018-22. PubMed ID: 1658792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement of the human immunodeficiency virus type 1 env gene sequence for TAR-independent trans activation by Tat from the major immediate-early promoter of murine cytomegalovirus.
    Kim YS
    Biochem Biophys Res Commun; 1994 Sep; 203(2):1152-9. PubMed ID: 8093034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transactivation of heterologous promoters by HIV-1 tat.
    Han P; Brown R; Barsoum J
    Nucleic Acids Res; 1991 Dec; 19(25):7225-9. PubMed ID: 1662814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Nef mediates post-translational down-regulation and redistribution of the mannose receptor.
    Vigerust DJ; Egan BS; Shepherd VL
    J Leukoc Biol; 2005 Apr; 77(4):522-34. PubMed ID: 15637102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of c-Fos in activated T lymphoid and monocytic cells by human immunodeficiency virus-1 Tat protein.
    Gibellini D; Caputo A; Capitani S; La Placa M; Zauli G
    Blood; 1997 Mar; 89(5):1654-64. PubMed ID: 9057648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein.
    Southgate C; Zapp ML; Green MR
    Nature; 1990 Jun; 345(6276):640-2. PubMed ID: 2190099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription.
    Rittner K; Churcher MJ; Gait MJ; Karn J
    J Mol Biol; 1995 May; 248(3):562-80. PubMed ID: 7752225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin T1 expression is mediated by a complex and constitutively active promoter and does not limit human immunodeficiency virus type 1 Tat function in unstimulated primary lymphocytes.
    Martin-Serrano J; Li K; Bieniasz PD
    J Virol; 2002 Jan; 76(1):208-19. PubMed ID: 11739686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV Tat protein requirements for transactivation and repression of transcription are separable.
    Brown JA; Howcroft TK; Singer DS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jan; 17(1):9-16. PubMed ID: 9436753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.